Related Experiment Video
Updated: Jun 2, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
[A case with severe combined immunodeficiency diagnosed with disseminated BCG infection by detecting specific RD gene
Mitsuko Akaihata1, Koichi Hashimoto, Yukihiko Kawasaki
1Department of Pediatrics, Fukushima Medical University.
Insights
Bacillus Calmette-Guérin (BCG) vaccination is recommended for infants in Japan. However, severe disseminated BCG infection can occur in infants with undiagnosed immunodeficiency, highlighting the need for caution.
Area of Science:
- Pediatrics
- Immunology
- Infectious Diseases
Background:
- Bacillus Calmette-Guérin (BCG) vaccination is standard for infants under 6 months in Japan to prevent severe tuberculosis forms.
- While generally safe, BCG can cause local inflammatory reactions and rarely severe adverse effects like disseminated BCG infection.
Observation:
- A case report of an 11-month-old boy with severe combined immunodeficiency (SCID).
- The patient developed fatal disseminated BCG infection after BCG vaccination at 4 months, prior to SCID diagnosis.
- Treatment with anti-tuberculosis therapy and blood stem cell transplantation was unsuccessful.
Findings:
- Disseminated BCG infection occurred in an infant with undiagnosed severe combined immunodeficiency.
- BCG vaccination in immunocompromised infants can lead to severe, life-threatening complications.
- Early diagnosis of immunodeficiency is crucial for preventing severe BCG-related adverse events.
Implications:
- Highlights the risk of severe BCG complications in infants with underlying immunological deficiencies.
- Underscores the importance of considering immunodeficiency in infants presenting with disseminated BCG infection.
- Suggests a need for careful patient selection or screening for immunodeficiency before BCG vaccination in at-risk populations.
Abstract:
Because the Bacillus Calmette-Guérin (BCG) prevents infants from contracting miliary tuberculosis and tuberculosis meningitis, BCG vaccination is recommended for those under 6 months old in Japan. Complications such as favorable local inflammatory reactions including redness, induration, and abscess formation may occur, but severe adverse effects such as osteomyelitis, periostitis, and disseminated BCG infection are generally rare. We report an 11-month-old boy with severe combined immunodeficiency dying of serious disseminated BCG infection despite anti-tuberculosis therapy and blood stem cell transplantation. He was vaccinated with disseminated BCG infection at 4 months before severe combined immunodeficiency diagnosis was confirmed by specific RD gene deletion based on allele-specific polymerase chain reaction. Although BCG is considered safe, we should keep in mind that subjects with immunological deficiency may suffer severe BCG complications.
More Related Videos
14:14Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
Published on: December 6, 2014
07:14A CFSE-based Assay to Study the Migration of Murine Skin Dendritic Cells into Draining Lymph Nodes During Infection with Mycobacterium bovis Bacille Calmette-Guérin
Published on: October 9, 2016
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease